摘要
目的探讨骨伤科1号方在治疗II型原发性骨质疏松症的临床疗效。方法:收治100例II型原发性骨质疏松症患者,随机分为治疗组和对照组各50例,对照组给予口服仙灵骨葆胶囊治疗,治疗组给予骨伤科1号方中药汤剂口服治疗。结果:治疗组总有效率为88%,高于对照组的74%,差异有统计学意义(P〈0.05);治疗后两组间骨密度及疼痛缓解情况(VAS评分)相比,治疗组均优于对照组(P〈0.05)。结论:骨伤科1号方治疗II型原发性骨质疏松症效果显著,有增加骨密度、抑制骨痛的作用值得临床推广。
Objective To investigate the clinical efficacy of the Gushang decoction on treating primary osteoporosis.Methods:100 patients with primary osteoporosis to our hospital were randomly divided into observation group and control group,50 in each.The control group was given Xianlinggubao Capsule; the observation group was given the Gushang decoction oral treatment.Compared the clinical efficacy of the two groups,before treatment and third months of treatment bone mineral density and low pain. Results:The total efficiencyof observation group was 88%, higher than 74% in the control group(P〈 0.05).3 months after treatment,two groups of bone density,the changes of the pain (VAS score) were obviously improved than before treatment (P〈0.05). Conclusion:Gushang decoction is effective on treating primary osteoporesis,it has obvious effect in treating low pain from primary osteoporosis,and increase bone density.It is worth the clinical promotion.
出处
《世界中医药》
CAS
2016年第B06期1774-1775,共2页
World Chinese Medicine